BiostatisticsPfizer IncNew York, New York, United States
Disclosure information not submitted.
Voxelotor for Sickle Cell Disease: Initial Report from the Real-World PROSPECT Study
Saturday, June 8, 20248:30 AM – 8:45 AM ET